Finance

Lists
Why is 600613 down 6,54%?
Dive Deeper
600613:SHA
Shanghai Shenqi Pharmaceutical Investment Management Ord Shs A
CN¥8,15
-6,54%
(-0,57) 1D
12 Okt., 10:20:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600613...
Open
CN¥8,52
High
CN¥8,72
Low
CN¥8,10
Mkt. cap
4,34 mjd
Avg. vol.
105,46 m
Volume
42,41 m
Dividend
0,86%
Quarterly dividend
CN¥0,02
Ex-dividend date
17 Jun. 2026
P/E ratio
158,90
52-wk high
CN¥12,77
52-wk low
CN¥4,33
EPS
CN¥0,05
Shares outstanding
479,32 m
No. of employees
1 k
Open
CN¥8,52
High
CN¥8,72
Low
CN¥8,10
Mkt. cap
4,34 mjd
Avg. vol.
105,46 m
Volume
42,41 m
Dividend
0,86%
Quarterly dividend
CN¥0,02
Ex-dividend date
17 Jun. 2026
P/E ratio
158,90
52-wk high
CN¥12,77
52-wk low
CN¥4,33
EPS
CN¥0,05
Shares outstanding
479,32 m
No. of employees
1 k
News stories
From web sources and news partners
About Shanghai Shenqi Pharmaceutical Investment Management Ord Shs A
CEO-
Employees1,2 k
Founded22 Jul. 1992
Headquarters-
SectorPharmaceutical industry
Websitegzsq.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
437,01 m
554,51 m
422,94 m
425,19 m
Cost of goods sold
221,29 m
348,47 m
232,06 m
255,15 m
Cost of revenue
221,29 m
348,47 m
232,06 m
255,15 m
Research and development expenses
7,91 m
8,48 m
7,04 m
7,68 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
169,03 m
186,17 m
148,02 m
136,08 m
Operating expense
185,83 m
211,87 m
169,08 m
148,61 m
Total operating expenses
407,11 m
560,34 m
401,14 m
403,76 m
Operating income
29,90 m
-5,83 m
21,80 m
21,43 m
Other non operating income
-1,06 m
-1,07 m
-1,84 m
-340,06 k
EBT including unusual items
19,70 m
5,71 m
19,41 m
17,69 m
EBT excluding unusual items
29,63 m
-5,90 m
19,66 m
21,75 m
Income tax expense
3,03 m
16,97 m
7,38 m
4,21 m
Effective tax rate
15,36%
296,96%
38,03%
23,82%
Other operating expenses
8,98 m
3,52 m
9,92 m
3,29 m
Net income
17,49 m
-12,06 m
12,88 m
9,08 m
Net profit margin
4,00%
-2,17%
3,05%
2,14%
Earnings per share
-
-
-
-
Interest and investment income
1,85 m
4,08 m
2,07 m
716,57 k
Interest expense
-1,07 m
-3,10 m
-2,37 m
-55,63 k
Net interest expenses
783,54 k
983,79 k
-305,41 k
660,94 k
Depreciation and amortization charges
-
-
-
-
EBITDA
49,34 m
12,75 m
40,38 m
41,62 m
Gain or loss from assets sale
-
-227,96 k
-
-51,12 k
AI content may include mistakes. Learn more
Google-programme